Lv4
478 积分 2024-06-19 加入
Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
28天前
已完结
Prospective, multicentre phase II study to evaluate the clinical benefit of reduced‐dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma
2个月前
已完结
A dexamethasone‐free daratumumab–ixazomib regimen in frail elderly patients with relapsed or refractory multiple myeloma: Results of the IFM 2018‐02 phase II study
2个月前
已完结
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA
5个月前
已完结
The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy
5个月前
已完结
Combining Radiation Therapy with Bispecific Antibodies: Outcomes in Relapsed/Refractory Hematologic Malignancies
5个月前
已关闭
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third‐Line CAR T
5个月前
已完结
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
5个月前
已完结
Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy
6个月前
已关闭
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma
7个月前
已完结
皖公网安备34019202002308
